Dodecanoylcarnitine

Dodecanoylcarnitine is present in fatty acid oxidation disorders such as long-chain acyl CoA dehydrogenase deficiency, carnitine palmitoyltransferase I/II deficiency, and is also associated with celiac disease. Dodecanoylcarnitine deomonstrates high sensitivities and specificities in predicting asthma[1][2].

Product Specifications

CAS Number

[25518-54-1]

Product Name Alternative

(-) -Lauroylcarnitine

UNSPSC

12352211

Hazard Statement

H315, H319, H335

Target

Endogenous Metabolite

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/Dodecanoylcarnitine.html

Purity

99.75

Solubility

DMSO : 33.33 mg/mL (ultrasonic)

Smiles

CCCCCCCCCCCC(O[C@H](CC([O-])=O)C[N+](C)(C)C)=O

Molecular Formula

C19H37NO4

Molecular Weight

343.50

Precautions

H315, H319, H335

References & Citations

[1]Shigematsu Y, et al. Selective screening for fatty acid oxidation disorders by tandem mass spectrometry: difficulties in practical discrimination. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 15;792 (1) :63-72.|[2]Zhu, T., et al., (2024) . Serum Metabolomics Reveals Metabolomic Profile and Potential Biomarkers in Asthma. Allergy, asthma & immunology research, 16 (3), 235–252.